ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0549

Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients

Priyanka Srivastava1 and Liza Rajasekhar2, 1International Institute of Information Technology, Hyderabad, India, 2Nizam's Institute of Medical Sciences, Madhapur, India

Meeting: ACR Convergence 2023

Keywords: Anxiety, Cognitive dysfunction, Measurement Instrument, mental health, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0543–0581) SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Reported prevalence of cognitive dysfunction (CD) in SLE varies from 3%-88%1.Variability may be due to use of tools insensitive to population characteristics like literacy, improper control groups and effect of psychological health. We developed a language agnostic computerized cognitive test battery to evaluate CD in SLE.

Methods: Patients fulfilling the 2012 classification criteria for SLE and their randomly chosen care-givers, attending outpatient services, able to provide written consent and sustain the duration of cognitive testing (CT) were enrolled as cases and controls respectively.

CT included 1 paper-and-pencil Montreal Cognitive Assessment (MoCA), and 4 modified computerized tests: attention network tests (ANT) for executive control; sustained attention to response task (SART) for continuous task performance, picture naming for language proficiency, and n-back for working memory (WM), which used familiar images like truck, bag, fan instead of numbers or colors. Developed with PsychoPy experiment design software, participants’ response time and accuracy was recorded. Depression, anxiety, stress, and trait anxiety were assessed using patient health questionnaire (PHQ-9), generalized anxiety disorder scale (GAD-7), perceived stress scale (PSS-4) and short state-trait anxiety inventory (STAI-T) respectively. Institutional Ethics committees approved the study. Scores were compared between groups using Mann Whitney U test with Bonferroni correction.

Results: Twenty-one SLE patients and 20 controls were enrolled. There was no difference in mean age (cases 27.7(6.5) controls 28(8.3) years) between groups. Mean duration of illness in cases was 61.8(42.5) months and mSLEDAI was 0. Table 1 shows mean scores of CT and psychological scales. Cases had reduced commission error (inappropriate response to a no-go stimulus), and increased accuracy for no-go conditions, but with overall response latency in SART (effect size, r= .43 , -0.43, -0.40 respectively). Cases had significantly higher GAD scores (effect size (r=-0.36) with overall 23% reporting moderate generalized anxiety symptoms. (Figure 1).

Conclusion: Unlike previous studies, though patients and caregivers had no difference in MOCA, patients had increased psychomotor latency. After validation in populations with higher literacy and use in larger sample size with proper controls the true prevalence of CD in SLE will emerge.

Reference: 1. Rayes HA Touma Z et al. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum. 2018 Oct;48(2):240-255.

Supporting image 1

Cognitive and psychological task response by SLE and HC group.

Supporting image 2

Figure 1. Raincloud plot depicting generalized anxiety disorder score (left panel) and patient health questionnaire score (right panel) . SLE=SLE patients and HC=healthy control.


Disclosures: P. Srivastava: None; L. Rajasekhar: None.

To cite this abstract in AMA style:

Srivastava P, Rajasekhar L. Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/development-of-customized-digital-cognitive-assessment-battery-a-pilot-use-case-in-sle-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-customized-digital-cognitive-assessment-battery-a-pilot-use-case-in-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology